BHST
BioHarvest Sciences Inc. Common StockBHST
BHST
–
Funds holding %
of 6,780 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for BHST.
Financial journalist opinion
Based on 11 articles about BHST published over the past 30 days
Neutral
Seeking Alpha
1 week ago
BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST ) Q3 2024 Earnings Conference Call November 25, 2024 4:30 PM ET Company Participants Justin Meiklem - IR Ilan Sobel - CEO Bar Dichter - CFO Zaki Rakib - President of Botanical Synthesis CDMO Business Unit Conference Call Participants Hunter Diamond - Diamond Equity Research Operator Greetings, and welcome to the BioHarvest Sciences Third Quarter 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
Negative
Zacks Investment Research
1 week ago
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago.
Positive
Proactive Investors
1 week ago
BioHarvest Sciences reports increased revenues, profits for Q3
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) reported robust financial performance for the third quarter ending September 30, 2024. The company achieved a 101% year-over-year revenue increase to $6.5 million, surpassing management's guidance.
Neutral
Newsfile Corp
1 week ago
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the third quarter ended September 30, 2024. Third Quarter & Subsequent 2024 Operational Highlights All figures stated in this news release are in U.S. dollars unless stated otherwise.
Positive
Proactive Investors
1 week ago
BioHarvest Sciences launches VINIA SuperFood Teas
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has expanded its product offerings with the launch of VINIA SuperFood Functional Teas, marking a strategic move into the $3.3 billion North American functional tea market. The new line features four premium blends: Black Tea, Green Tea, Matcha Green Tea, and Cranberry Hibiscus Herbal Tea, each infused with piceid resveratrol, the active ingredient from the company's clinically validated VINIA supplements.
Neutral
Newsfile Corp
1 week ago
BioHarvest Launches VINIA SuperFood Functional Tea Line
Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood Tea Infused with Piceid Resveratrol Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced the launch of its highly anticipated VINIA® infused teas - a line of SuperFood functional teas that deliver the same clinically validated benefits as the successful VINIA® supplements. This launch further demonstrates the potential of VINIA's lifetime value across multiple consumer verticals.
Neutral
Newsfile Corp
1 week ago
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place on December 3, 2024. CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a presentation for in-person attendees.
Neutral
Newsfile Corp
2 weeks ago
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024. Management will host an investor conference call at 4:30 p.m.
Positive
Proactive Investors
3 weeks ago
BioHarvest shares rise in Nasdaq debut
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) began trading on the Nasdaq Global Market on Tuesday under the ticker symbol "BHST." Shares of the company gained nearly 5% in early morning trading, reaching US$6 just after the opening bell.
Neutral
Newsfile Corp
3 weeks ago
BioHarvest Sciences Begins Trading on the Nasdaq Global Market
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 12, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Company's shares will begin trading on the Nasdaq Global Market ("Nasdaq") at the opening of the U.S. market today under the new ticker symbol "BHST". The Company's common shares will continue to trade on the Canadian Securities Exchange ("CSE").
Charts implemented using Lightweight Charts™